Evidence map›Paper›PMID 23349463›Full record

ArticleThe Journal of biological chemistry2013

Binding interactions with the complementary subunit of nicotinic receptors.

Angela P Blum, Ethan B Van Arnam, Laurel A German, Henry A Lester, Dennis A Dougherty

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Angela P BlumDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.
Ethan B Van Arnam
Laurel A German
Henry A Lester
Dennis A Dougherty
California Institute of Technology · US

Funding

NICOTINIC SYNAPSES, BIOPHYSICAL STUDIESR01NS011756 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 1985 to 2009
$3.4M
PROBING RECEPTOR STRUCTURES WITH UNNATURAL AMINO ACIDSR01NS034407 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI DOUGHERTY, DENNIS A · 1995 to 2016
$3.1M
Probing Receptor Structures with Unnatural Amino AcidsR37NS034407 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI DOUGHERTY, DENNIS A · 2004 to 2010
$2.7M
NINDS NIH HHS NS11756NINDS NIH HHS NS34407NINDS NIH HHS R01 NS011756NINDS NIH HHS R01 NS034407NINDS NIH HHS R37 NS034407
6 · The paper itself

Abstract

The agonist-binding site of nicotinic acetylcholine receptors (nAChRs) spans an interface between two subunits of the pentameric receptor. The principal component of this binding site is contributed by an α subunit, and it binds the cationic moiety of the nicotinic pharmacophore. The other part of the pharmacophore, a hydrogen bond acceptor, has recently been shown to bind to the complementary non-α subunit via the backbone NH of a conserved Leu. This interaction was predicted by studies of ACh-binding proteins and confirmed by functional studies of the neuronal (CNS) nAChR, α4β2. The ACh-binding protein structures further suggested that the hydrogen bond to the backbone NH is mediated by a water molecule and that a second hydrogen bonding interaction occurs between the water molecule and the backbone CO of a conserved Asn, also on the non-α subunit. Here, we provide new insights into the nature of the interactions between the hydrogen bond acceptor of nicotinic agonists and the complementary subunit backbone. We studied both the nAChR of the neuromuscular junction (muscle-type) and a neuronal subtype, (α4)2(β4)3. In the muscle-type receptor, both ACh and nicotine showed a strong interaction with the Leu NH, but the potent nicotine analog epibatidine did not. This interaction was much attenuated in the α4β4 receptor. Surprisingly, we found no evidence for a functionally significant interaction with the backbone carbonyl of the relevant Asn in either receptor with an array of agonists.

Indexed as

AcetylcholineAmino Acid SequenceAnimalsAsparagineBinding SitesBridged Bicyclo Compounds, HeterocyclicFemaleHumansHydrogen BondingLeucineMembrane PotentialsModels, MolecularMolecular Sequence DataMolecular StructureMutationNicotineAcetylcholinealpha(4)beta(4) nicotinic receptorAsparagineBridged Bicyclo Compounds, HeterocyclicepibatidineLeucineNicotinenicotinic receptor alpha4beta2PyridinesReceptors, Nicotinic

Identifiers

PMID23349463
PMCPMC3591609
OpenAlexW2005181420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.